After the market closed on April 6, 2022, HTC Molecular Diagnostics Inc. (HTGM) announced new features of its proprietary HTG EdgeSeq technology. The news caused
Shares of the life science company HTG Molecular Diagnostics Inc. (HTGM), whose mission is to advance precision medicine, has gained 8.57% in Monday’s session to
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.